Abbreviated Name

Pancreatic Ref Set App: Ohtsuki/Honda (2019)

Lead Investigator

Ohtsuki, Sumio — Kumamoto University

Coordinating Investigator

Feng, Ziding — Fred Hutchinson Cancer Center

Involved Investigators

• Feng, Ziding — Fred Hutchinson Cancer Center
• Honda, Kazufumi — Nippon Medical School
• Ohtsuki, Sumio — Kumamoto University

Abstact

No abstract availalbe.

Aims

No aims available.

Analytic Method

No analytic method available.

Outcome

For separating all cancer (or early stage cancer) from healthy controls, the three-marker score constructed from DYI, THL, and LLP has better AUC estimate compared to CA199 and significant coefficent in the logistic regression model after adjusting for CA199. It also has better AUC compared to CA199 and significant improvement in AUC when combined with CA199 for separating all cancer, early stage cancer, or late stage cancer)from acute benign biliary obstruction.

Publications

• No publications available at this time for this protocol.

Biomarkers

• APOA1
• APOA2
• CA19-9
• Tryptic peptide ApoA1
• Tryptic peptide APoA2
• Tryptic peptide IT1H3

Data Collections

• No data collections available at this time for this protocol.

 Team Project

Start Date

Feb 20 2019

Estimated Finish Date

Feb 20 2020

Finish Date

Sep 3 2019

Protocol ID

454

Protocol Type

Reference Set

Field of Research

UNKNOWN

Collaborative Group

G.I. and Other Associated Cancers Research Group

Cancer Types

• Malignant neoplasm of pancreas

Phased Status

1